$AMIH News Out -
Pharmacy to Pay for Access to ZipDoctor’s 24/7 Medical Services on its Telemedicine Platform
Dallas, Texas, Aug. 26, 2021 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), a diversified holding company that develops, acquires and operates technology-based health and wellness companies, today announced its wholly-owned subsidiary, ZipDoctor, Inc., has executed a telemedicine services agreement with Murphy RX (“Murphy”), a Texas-based specialty pharmacy that provides its customers with prescriptions, specialty compounding, vaccinations, diabetes care, medical equipment, various OTC remedies, as well as a full range of cosmetic products, vitamins and more.
Under the terms of the Agreement, ZipDoctor will develop and provide Murphy with access to a centralized technology platform to collect and manage patient demographics, insurance information, and collect acute health information for the purpose of being reviewed for treatment by ZipDoctor’s network of providers.
Murphy will offer its customers/patients access to ZipDoctor’s suite of telemedicine services currently available through its website at www.ZipDoctor.co with all telemedicine services being provided by ZipDoctor and its network of providers. Murphy will pay ZipDoctor a monthly fee on a per-patient basis for the use of the technology platform and for access to its currently available primary care telemedicine services.
As AMIH Chief Executive Officer, Jacob Cohen, discussed in his May 11, 2021, Letter to Shareholders, the Company’s ongoing build-out of Epiq MD, a low-cost telehealth platform, was based on data gathered from ZipDoctor’s beta and test-marketing phases, which occured last year. Accordingly, and as previously stated in that Letter to Shareholders, ZipDoctor has now officially pivoted to a niche business-to-business (B2B) model, which it expects to grow through strategic partnerships with pharmacies and similar companies.
“This is a groundbreaking win all around,” Mr. Cohen said. “Murphy better serves its customers by paying to provide them access to our robust, 24/7 proprietary telemedicine platform for a valuable medical benefit that increases efficiency by ensuring their prescriptions status is reviewed by medical professionals – which we believe boosts those customers’ loyalty. We are already planning to replicate and scale this model with other specialty and compounding pharmacies nationwide,” he added.”
https://finance.yahoo.com/news/amih-zipdoctor...00953.html
Pharmacy to Pay for Access to ZipDoctor’s 24/7 Medical Services on its Telemedicine Platform
Dallas, Texas, Aug. 26, 2021 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), a diversified holding company that develops, acquires and operates technology-based health and wellness companies, today announced its wholly-owned subsidiary, ZipDoctor, Inc., has executed a telemedicine services agreement with Murphy RX (“Murphy”), a Texas-based specialty pharmacy that provides its customers with prescriptions, specialty compounding, vaccinations, diabetes care, medical equipment, various OTC remedies, as well as a full range of cosmetic products, vitamins and more.
Under the terms of the Agreement, ZipDoctor will develop and provide Murphy with access to a centralized technology platform to collect and manage patient demographics, insurance information, and collect acute health information for the purpose of being reviewed for treatment by ZipDoctor’s network of providers.
Murphy will offer its customers/patients access to ZipDoctor’s suite of telemedicine services currently available through its website at www.ZipDoctor.co with all telemedicine services being provided by ZipDoctor and its network of providers. Murphy will pay ZipDoctor a monthly fee on a per-patient basis for the use of the technology platform and for access to its currently available primary care telemedicine services.
As AMIH Chief Executive Officer, Jacob Cohen, discussed in his May 11, 2021, Letter to Shareholders, the Company’s ongoing build-out of Epiq MD, a low-cost telehealth platform, was based on data gathered from ZipDoctor’s beta and test-marketing phases, which occured last year. Accordingly, and as previously stated in that Letter to Shareholders, ZipDoctor has now officially pivoted to a niche business-to-business (B2B) model, which it expects to grow through strategic partnerships with pharmacies and similar companies.
“This is a groundbreaking win all around,” Mr. Cohen said. “Murphy better serves its customers by paying to provide them access to our robust, 24/7 proprietary telemedicine platform for a valuable medical benefit that increases efficiency by ensuring their prescriptions status is reviewed by medical professionals – which we believe boosts those customers’ loyalty. We are already planning to replicate and scale this model with other specialty and compounding pharmacies nationwide,” he added.”
https://finance.yahoo.com/news/amih-zipdoctor...00953.html
